The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
olmesartan medoxomil and hydrochlorothiazide · OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC 50090-7127-00 · 90 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 43547-0392-03) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.3983per unit
middle half $0.1996–$0.6828 · 5,334 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.3983
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
97%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 82%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 1 quarter since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for olmesartan medoxomil and hydrochlorothiazide (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market · price up 4% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- A-S Medication Solutions LLCUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA207804
- TE code
- AB
- Approval date
- Apr 24, 2017
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of olmesartan medoxomil and hydrochlorothiazide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Aug 31, 2026 |
| A-S Medication Solutions | OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 22, 2026 |
| Bryant Ranch Prepack | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 22, 2026 |
| A-S Medication Solutions | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| A-S Medication Solutions | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Inc. | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Inc. | OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Inc. | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Bryant Ranch Prepack | OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Bryant Ranch Prepack | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Remedyrepack Inc. | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Solco Healthcare US, LLC | OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Solco Healthcare US, LLC | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Solco Healthcare US, LLC | OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Bryant Ranch Prepack | HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Jul 19, 2026 |
| Bryant Ranch Prepack | HYDROCHLOROTHIAZIDE 25 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Jul 16, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE — NDC 50090-7127-00," retrieved September 3, 2026, https://drugdashboards.com/drug/50090712700.
Free to cite with attribution — see how the data is put together.